Scilex Holding (SCLX) Other financing activities (2020 - 2024)
Scilex Holding (SCLX) posted quarterly Other financing activities of $200000.0 for Q4 2024, down 47.37% year-over-year from $380000.0 in Q1 2024, and up 107.06% on a QoQ basis from -$2.8 million in Q3 2024.
Scilex Holding (SCLX) Other financing activities (2020 - 2024) Analysis & Trends
Scilex Holding (SCLX) has reported Other financing activities for 4 consecutive years, with $200000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Other financing activities fell 47.37% year-over-year to $200000.0; the TTM figure through Sep 2025 stood at $200000.0 (down 47.37% YoY), while the FY2024 annual figure was $200000.0, down 47.37% from the prior year.
- Other financing activities came in at $200000.0 for Q4 2024 at Scilex Holding, up from -$2.8 million in the prior quarter.
- The five-year high for Other financing activities was $1.6 million in Q2 2024, with the low at -$2.8 million in Q3 2024.
- Average Other financing activities over 4 years is $59114.8, with a median of $200000.0 recorded in 2024.
- Across the five-year window, Other financing activities tumbled 692.3% in 2021 and jumped 309.74% in 2024, its largest moves.
- Year by year, Other financing activities stood at $118213.0 in 2020, then slumped by 452.13% to -$416260.0 in 2021, then surged by 191.29% to $380000.0 in 2023, then plunged by 47.37% to $200000.0 in 2024.
- According to Business Quant data, Other financing activities over the past three periods registered $200000.0, -$2.8 million, and $1.6 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | -2.83 Mn |
| Sep 30, 2024 | -2.83 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 380,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Sep 30, 2023 | -380,000.00 |
| Sep 30, 2023 | -380,000.00 |
| Jun 30, 2023 | 380,000.00 |
| Jun 30, 2023 | 380,000.00 |
| Dec 31, 2021 | -416,260.00 |
| Dec 31, 2021 | -416,260.00 |
| Sep 30, 2021 | -416,260.00 |
| Sep 30, 2021 | -416,260.00 |
| Jun 30, 2021 | 416,260.00 |
| Jun 30, 2021 | 416,260.00 |